Submitted by Anonymous (not verified) on 7 July 2025 - 15:45
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 23, Status: Authorised